Scott v. Glenmark Pharmaceuticals Limited et al
| Leroy Scott |
| Walgreens Louisiana Co. Inc. and Glenmark Pharmaceuticals Limited |
| 9:2021cv80501 |
| March 8, 2021 |
| U.S. District Court for the Southern District of Florida |
| Robin L Rosenberg |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 |
| Defendant |
Docket Report
This docket was last retrieved on March 9, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 11
ORDER OF CONSOLIDATION AND ADMINISTRATIVE CLOSE-OUT. Signed by Judge Robin L. Rosenberg on 3/9/2021. See attached document for full details. (mc)
|
| Filing 10 MDL Transfer In Case Receipt from Eastern District of Louisiana. Case Number 21-cv-00349 with documents 1-7. Assigned FLSD Case Number 9:21-cv-80501-RLR on 3/8/2021. Re: FLSD MDL Case Number 9:20-md-02924-RLR. (mc) |
| Filing 9 Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg. (mc) |
| Filing 8 Case transferred in from Louisiana Eastern; Case Number 2:21-cv-00349. Electronic file including transfer order and docket sheet received. .(mc). |
Filing 7
Order of MDL Transfer to District of Florida Southern. MDL case number is 2924. Electronic file, certified copy of transfer order, and docket sheet sent. (Attachments: #1 Transmittal Letter, #2 Transmittal Letter)(jeg)
|
| Filing 6 Notice of Conditional Transfer Order from MDL Panel regarding MDL 2924. (lt) |
| Filing 5 Correction of Docket Entry by Clerk re #1 Notice of Removal. Filing attorney did not properly format the pdf Civil Cover Sheet. The pdf should have been flattened. When using a FORM, fill in the applicable fields then click PRINT to adobe pdf to flatten the document to pdf format. Clerk has taken corrective action. Also, the Statement of Corporate Discloure should be filed as a separate docket entry instead of an attachment to the Notice of Removal. Clerk took corrective action by separating this attachment(s) and docketing it as a separate entry. (lt) |
| Filing 4 Statement of Corporate Disclosure by Glenmark Pharmaceuticals Limited. (lt) |
| Filing 3 Directive of the Clerk regarding compliance 28:1447(b) re #1 Notice of Removal, filed by Glenmark Pharmaceuticals Limited. (lt) |
| Filing 2 Initial Case Assignment to Judge Wendy B Vitter and Magistrate Judge Donna Phillips Currault. (go) |
| Filing 1 NOTICE OF REMOVAL from Civil District Court for the Parish of Orleans, case number 2020-10281, B-5 (Filing fee $ 402 receipt number ALAEDC-8740162) filed by Glenmark Pharmaceuticals Limited. (Attachments: #1 Exhibit A - In re Zantac, #2 Exhibit B - State Court Pleadings, #3 Exhibit C - Notice of Filing, #4 Appendix Rule 7.1 Corporate Disclosure Statement, #5 Civil Cover Sheet)Attorney Patrick B. Reagin added to party Glenmark Pharmaceuticals Limited(pty:dft).(Reagin, Patrick) (Attachment 5 replaced on 2/19/2021) (lt). Modified text on 2/19/2021 (lt). |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.